GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aelis Farma AELIS.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.94

-7.84%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Aelis Farma — daily AELIS

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Aelis Farma on TradingView ↗
Market value
€12.9m
Last close × shares
Volume
38.4k
Shares, 9 Nov 2026

About Aelis Farma

Its shares trade on Euronext Paris under the ticker AELIS.PA. It has been listed since 18 February 2022. In the fiscal year to 31 December 2025, it reported revenue of €2.1m and a net loss of €6.4m. At that date it held total assets of €12.0m and shareholders' equity of €4.4m.

Aelis Farma SA engages in the research and development of pharmaceutical products. The company is headquartered in Bordeaux, Nouvelle-Aquitaine. The company went IPO on 2022-02-18. The firm provides two products in clinical development, including AEF0117 for cannabis-related disorders (severe dependence, acute psychosis, and acute toxicity), and AEF0217 for cognitive deficits (disorders related to Down syndrome). The company offers viable treatments for certain pathological conditions linked to hyperactivity of the CB1 receptor, the main receptor of the endocannabinoid system. The company provides advanced drug AEF0117, to combat the harmful effects of cannabis and in particular Cannabis Use Disorders (CUD) which is the current definition of cannabis addiction in the diagnostic manual reference DSM-5. The firm operates a Research and Development (R&D) platform, which enables the Company to discover drug candidates that act as specific modulators of target receptor signaling.

Figures and description from our data supplier, not checked against the company's own report.

More about Aelis Farma →

Latest on Aelis Farma

Our reporting

We have not reported on Aelis Farma yet.

Next results

5 Apr 2027

Due on 5 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Aelis Farma's ticker?

Aelis Farma trades as AELIS.PA on Euronext Paris, under ISIN FR0014007ZB4.

What was Aelis Farma's last closing price?

0.94 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Aelis Farma next report results?

Results are expected on 5 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.